What is it?
Vaxo-Q-Re is a new advanced therapy consisting of five types of immune cells: macrophages, NK cells, dendritic cells, cytotoxic T lymphocytes and antibody producing plasma cells. Tested on breast cancer cells but effective at treating all forms of the disease, the adoptive T cell-based therapy encourages the body’s immune system to target cancer cells.
Who Uses it and How Does it Work?
Vaxo-Q-Re has been in development by RGCC scientists for more than five years and is now categorized as a Cell Therapy Medicinal Product (CTMP) by the European Medicines Agency (EMA). Vaxo-Q-Re is available exclusively to RGCC Network doctors.
The test requires a 150 cc sample of blood to make concoction of your immune cells that is safe to infuse back into the body by a standard IV. This large influx of immune cells should significantly improve your body's ability to fight cancer
Where Can I Get More Information?
If you are interested in more information about this therapy, please contact our office to schedule an appointment.
Additional information is available at https://www.rgcc-group.com/rgcc-therapies/